Caplight Directory>Companies>Sensulin-preview>Sensulin


Sensulin

Sensulin

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://www.sensulin.com/

Last Round

Series A

Dec 16, 2021

Total Funding Raised

$4.7M

Momentum Score

50 /100

Company Overview

Sensulin is a biopharmaceutical company that is developing a glucose-responsive insulin for type 1 and type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

glucose responsive insulinsmart insulindiabetes treatmentchemical pancreasdrug delivery platformonce daily insulinpreclinical biopharmahypoglycemia risk reductionliposome drug deliveryType 1 diabetesType 2 diabetesAgglomerated Vesicle TechnologyAVTbasal insulin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sensulin Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sensulin Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 16, 2021
VC RoundMay 25, 2018
GrantDec 1, 2013
SeedFeb 1, 2013
GrantSep 1, 2009
View all Funding Rounds

Sensulin Investors

Notable investors and investment history

InvestorRounds
National Institute of Diabetes and Digestive and Kidney DiseasesGrant
StartUp HealthSeries A
Cortado VenturesSeries A
National Science FoundationGrant
angelMDVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 68% MoM, reaching 5.4K.

  • Dec 16, 2021

    $4M round with participation from StartUp Health and Cortado Ventures.

View all signals

Sensulin Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sensulin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sensulin's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range6
Year Founded2011
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.